Predictions
Intel Corp.
Start price
Target price
Perf. (%)
€41.82
21.08.20
21.08.20
€48.00
04.11.21
04.11.21
7.72%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Charter Communications Inc. A
Start price
Target price
Perf. (%)
€521.60
21.08.20
21.08.20
€625.00
04.11.21
04.11.21
13.08%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Charter Communications Inc. A
Start price
Target price
Perf. (%)
€521.60
21.08.20
21.08.20
€625.00
04.11.21
04.11.21
13.08%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Charter Communications Inc. A
Start price
Target price
Perf. (%)
€521.60
21.08.20
21.08.20
€625.00
04.11.21
04.11.21
13.08%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Twitter Inc.
Start price
Target price
Perf. (%)
€32.75
21.08.20
21.08.20
€42.00
14.10.20
14.10.20
22.83%
14.10.20
14.10.20
Could be worthwhile Investment >10% per year
Known brand
Top 10 in its market
CHF Solutions Inc
Start price
Target price
Perf. (%)
-
20.08.20
20.08.20
€2.00
23.08.20
23.08.20
-
23.08.20
23.08.20
Could be very worthwhile Investment >20% year
Delivery Hero SE
Start price
Target price
Perf. (%)
€98.40
20.08.20
20.08.20
€125.00
04.11.21
04.11.21
20.48%
18.12.20
18.12.20
Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
Shop Apotheke Europe NV
Start price
Target price
Perf. (%)
€155.40
20.08.20
20.08.20
-
05.09.20
05.09.20
-18.92%
05.09.20
05.09.20
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
positive Cash Flow expected
AstraZeneca plc
Start price
Target price
Perf. (%)
€95.39
20.08.20
20.08.20
€105.50
04.11.21
04.11.21
1.68%
14.06.21
14.06.21
Future proof or reliable business model
Small cyclical dependencies
Known brand
AstraZeneca plc
Start price
Target price
Perf. (%)
€95.39
20.08.20
20.08.20
€105.50
04.11.21
04.11.21
1.68%
14.06.21
14.06.21
Future proof or reliable business model
Small cyclical dependencies
Known brand
Vornado Realty Trust
Start price
Target price
Perf. (%)
€29.20
19.08.20
19.08.20
-
25.10.20
25.10.20
-2.05%
25.10.20
25.10.20
High dividend yield expected
Significant cyclical dependencies
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Invesco Ltd.
Start price
Target price
Perf. (%)
€8.78
19.08.20
19.08.20
-
23.10.20
23.10.20
32.31%
23.10.20
23.10.20
Future proof or reliable business model
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Below average Management
Organovo Holdings Inc.
Start price
Target price
Perf. (%)
€7.40
19.08.20
19.08.20
€0.000
04.11.21
04.11.21
-23.65%
05.11.21
05.11.21
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€55.59
19.08.20
19.08.20
€52.00
24.08.20
24.08.20
0.76%
24.08.20
24.08.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€55.59
19.08.20
19.08.20
€52.00
24.08.20
24.08.20
0.76%
24.08.20
24.08.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€55.59
19.08.20
19.08.20
€52.00
24.08.20
24.08.20
0.76%
24.08.20
24.08.20
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Schaeffler AG
Start price
Target price
Perf. (%)
€6.47
19.08.20
19.08.20
€6.90
04.11.21
04.11.21
2.16%
02.02.21
02.02.21
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Innovative
Restaurant Brands Intl Inc.
Start price
Target price
Perf. (%)
€46.80
19.08.20
19.08.20
€60.00
04.11.21
04.11.21
1.72%
28.01.21
28.01.21
Top 10 in its market
Known brand
Restaurant Brands Intl Inc.
Start price
Target price
Perf. (%)
€46.80
19.08.20
19.08.20
€60.00
04.11.21
04.11.21
1.72%
28.01.21
28.01.21
Top 10 in its market
Known brand
Hello Group Inc. ADR
Start price
Target price
Perf. (%)
€18.25
19.08.20
19.08.20
€17.00
04.11.21
04.11.21
-39.18%
05.11.21
05.11.21
Could be very worthwhile Investment >20% year
Future proof or reliable business model
Small cyclical dependencies
Revenue growth >5% per year expected